Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Salivary Gland Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Anus Neoplasms 2 Vulvar Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sezary Syndrome 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Penile Neoplasms 1 Pelvic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms, Squamous Cell 1 Neoplasms 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Leukemia, Prolymphocytic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1

Interventions

Radiotherapy 4 Surveys and Questionnaires 3 Specimen Handling 2 Iohexol 2 Gemcitabine 2 spartalizumab 1 sodium thiosulfate 1 serotonin adipinate 1 liposomal doxorubicin 1 X-Rays 1 Watchful Waiting 1 Vorinostat 1 Surgical Procedures, Operative 1 Sunitinib 1 Solutions 1 Serotonin 1 Saline Solution 1 Re-Irradiation 1 Radiotherapy, Image-Guided 1 Radiosurgery 1 Probiotics 1 Platinum 1 Particle Accelerators 1 Pafolacianine 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Lidocaine 1 Ketamine 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pelvic Neoplasms × Vorinostat × Gynecologic × Clear all

NCT00455351 2023-05-08

PRAVO

Oslo University Hospital

Phase 1 Completed

Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡